Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals

Endocrine
Masahide HamaguchiMichiaki Fukui

Abstract

Recent studies identified that metabolically abnormal non-obese phenotype is a risk factor for cardiovascular diseases. However, little is known about risk factor for progression from metabolically healthy non-overweight to metabolically abnormal phenotype. We hypothesized that fatty liver had a clinical impact on progression from metabolically healthy non-overweight to metabolically abnormal phenotype. In this retrospective cohort study, 14,093 Japanese (7557 men and 6736 women), who received the health-checkup program from 2004 to 2012, were enrolled. Overweight and obesity were defined as body mass index 23.0-25.0 and ≥25.0 kg/m2. Four metabolic factors (impaired fasting glucose, hypertension, hypertriglyceridemia and low high density lipoprotein-cholesterol concentration) were used for definition of metabolically healthy (less than two factors) or metabolically abnormal (two or more). We divided the participants into three groups: metabolically healthy non-overweight (9755 individuals, men/women = 4290/5465), metabolically healthy overweight (2547 individuals, 1800/747) and metabolically healthy obesity (1791 individuals, 1267/524). Fatty liver was diagnosed by ultrasonography. Over the median follow-up period of 5.3 years,...Continue Reading

References

Feb 10, 1996·BMJ : British Medical Journal·M AshwellK McPherson
Aug 28, 2004·Clinics in Liver Disease·Arthur J McCullough
Nov 17, 2005·Annals of Internal Medicine·Masahide HamaguchiKazunori Ida
May 10, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·K G M M AlbertiJ Shaw
Jan 9, 2007·The American Journal of Clinical Nutrition·Antonino De LorenzoLaura Di Renzo
Apr 28, 2007·World Journal of Gastroenterology : WJG·Masahide HamaguchiToshikazu Yoshikawa
May 19, 2007·The American Journal of Gastroenterology·Ayako SuzukiKeith Lindor
Aug 30, 2008·Endocrine Reviews·Norbert StefanHans-Ulrich Häring
May 28, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ruben HernaezJeanne M Clark
Apr 18, 2012·World Journal of Gastroenterology : WJG·Masahide HamaguchiJun Takeda
Sep 6, 2012·Circulation·Jean-Pierre Després
Dec 4, 2013·Annals of Internal Medicine·Caroline K KramerRavi Retnakaran
Mar 4, 2014·Journal of Diabetes and Its Complications·Nathaniel J ColemanLeon Fogelfeld
Apr 20, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·Christopher D Byrne, Giovanni Targher
Jul 12, 2014·European Journal of Endocrinology·Matthias Blüher
Sep 23, 2014·Journal of Gastroenterology and Hepatology·Yoshitaka HashimotoMichiaki Fukui
Dec 11, 2014·World Journal of Gastroenterology : WJG·Ludovico AbenavoliStefano Bellentani
Dec 18, 2014·Reviews on Recent Clinical Trials·Mario MasaroneMarcello Persico
Dec 18, 2014·Clinical Science·Roy Taylor, Rury R Holman
Jan 31, 2015·Clinical Journal of the American Society of Nephrology : CJASN·Yoshitaka HashimotoMichiaki Fukui
Apr 12, 2015·Metabolism: Clinical and Experimental·Nathalie EckelMatthias B Schulze
Apr 15, 2015·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Z CuiJ Stevens
Apr 30, 2015·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Y-C HwangE J Boyko
Jul 16, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Takuya FukudaMichiaki Fukui
Aug 15, 2015·International Journal of Obesity : Journal of the International Association for the Study of Obesity·R DobsonD J Cuthbertson
Sep 9, 2015·Eating and Weight Disorders : EWD·Laura Di RenzoAntonino De Lorenzo
Oct 8, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Yukiko FukudaMichiaki Fukui
Oct 20, 2015·Metabolism: Clinical and Experimental·Amedeo LonardoGiovanni Targher
Feb 10, 2016·Metabolism: Clinical and Experimental·Jonathan M HazlehurstJeremy W Tomlinson
Apr 10, 2016·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Y HashimotoM Fukui
Jun 28, 2016·European Journal of Gastroenterology & Hepatology·Yoshitaka HashimotoMichiaki Fukui
Oct 21, 2016·European Journal of Gastroenterology & Hepatology·Takuya FukudaMichiaki Fukui
Sep 10, 2016·World Journal of Gastroenterology : WJG·Ludovico AbenavoliAntonino De Lorenzo

❮ Previous
Next ❯

Citations

Mar 3, 2018·F1000Research·Sarah FaasseMiriam Vos
Jan 23, 2019·Diabetes, Obesity & Metabolism·Dharambir K SangheraPiers R Blackett
Nov 7, 2019·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Takuro OkamuraMichiaki Fukui
May 5, 2020·American Journal of Physiology. Gastrointestinal and Liver Physiology·Takuro OkamuraMichiaki Fukui
Jan 7, 2020·Mini Reviews in Medicinal Chemistry·Hui LiJian Jiao
Aug 9, 2020·Frontiers in Physiology·Simone CarottiUmberto Vespasiani-Gentilucci
Jun 13, 2020·Diabetology & Metabolic Syndrome·Yun-Sheng WangWu Dai
Sep 17, 2019·The Journal of Clinical Investigation·Gordon I SmithSamuel Klein
Feb 3, 2021·Liver International : Official Journal of the International Association for the Study of the Liver·Paula IruzubietaJavier Crespo
Jun 18, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Jie MinLulu Chen
May 1, 2021·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·In Young ChoSeungho Ryu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.